{"url_path":"/sec/bicx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1443863/0001477932-26-003159-index.html","accession_number":"0001477932-26-003159","cik":"0001443863","ticker":"BICX","issuer_name":"BioCorRx Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1443863/0001477932-26-003159-index.html","primary_entity_key":"0001443863","primary_entity_name":"BioCorRx Inc."},"word_count":293,"has_tables":true,"body_markdown":"ITEM 6. EXHIBITS.\n\n \n\n[10.1](http://www.sec.gov/Archives/edgar/data/1443863/000147793226001957/bicx_ex101.htm)\n\n \n\n[Form of Stock Exchange Agreement, dated March 26, 2026 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 2, 2026).](http://www.sec.gov/Archives/edgar/data/1443863/000147793226001957/bicx_ex101.htm)\n\n[31.1**](bicx_ex311.htm)\n\n \n\n[Certifications of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](bicx_ex311.htm)\n\n[31.2**](bicx_ex312.htm)\n\n \n\n[Certifications of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](bicx_ex312.htm)\n\n[32.1](bicx_ex321.htm)\n\n \n\n[Certifications of Chief Executive Officer pursuant to 18 U.S.C. SEC. 1350 (Section 906 of Sarbanes-Oxley Act of 2002) +](bicx_ex321.htm)\n\n[32.2](bicx_ex322.htm)\n\n \n\n[Certifications of Chief Financial Officer pursuant to 18 U.S.C. SEC. 1350 (Section 906 of Sarbanes-Oxley Act of 2002) +](bicx_ex322.htm)\n\n101.INS\n\n \n\nInline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).\n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema Document.\n\n101.CAL\n\n \n\nInline XBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEF\n\n \n\nInline XBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LAB\n\n \n\nInline XBRL Taxonomy Extension Labels Linkbase Document.\n\n101.PRE\n\n \n\nInline XBRL Taxonomy Extension Presentation Linkbase Document.\n\n104\n\n \n\nCover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).\n\n_______________\n\n**\n\nFiled herewith.\n\n \n\n \n\n+\n\nIn accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.\n\n \n\n \n\n48\n\n*Table of Contents*\n\n \n\n **SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\nBIOCORRX INC.\n\n \n\n \n\n \n\n \n\nDate: May 15, 2026\n\nBy:\n\n*/s/ Lourdes Felix*\n\n \n\n \n\n \n\nLourdes Felix\n\n \n\n \n\n \n\nChief Executive Officer and Chief Financial Officer\n\n \n\n \n\n \n\n49"}